Product Overview
This investigational peptide is a triple receptor agonist that engages GLP1, GIP, and glucagon pathways. Current research focuses on how this combined activity may support metabolic function, weight regulation, and insulin response. Early findings suggest that multi receptor models can offer more insight than single or dual targeting approaches.
Research interest includes:
- Weight and metabolic regulation models
- Glucose control and Type 2 diabetes studies
- Lipid metabolism and energy balance research
- Development of multi hormonal metabolic therapy concepts
Applications in Research
- GLP1, GIP, and glucagon synergy studies
- Body composition and energy use investigations
- Glycemic control and insulin response analysis
- Preclinical evaluation of next generation incretin based compounds
Storage and Handling
Store the lyophilized material at minus 20 degrees Celsius in a dark and dry location.
Reconstitute with bacteriostatic water using sterile technique. After reconstitution, refrigerate at 2 to 8 degrees Celsius and use within standard research timelines. Limit freeze thaw cycles.




